Paul Wrighton, PhDSenior Scientist II, In Vivo Gene Editing at Editas MedicineSpeaker
Profile
Paul received his PhD from the University of Wisconsin where he investigated the involvement of the extracellular matrix on human pluripotent stem cell differentiation. He completed a postdoctoral fellowship at Brigham and Women’s Hospital and Harvard Medical School, developing in vivo imaging methods to study mitophagy. He began at Editas Medicine in 2021 as a member of the discovery biology team, developing in vivo gene editing medicines targeting the eye and liver.
Agenda Sessions
In Vivo CRISPR Editing of Genetic Regulatory Regions Results in Functional Upregulation of Target Protein and Reduction of Disease-Associated Biomarker
, 5:15pmView Session